Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients

被引:0
作者
Mirjam E. Mast
Eline J. Vredeveld
Herman M. Credoe
Jaap van Egmond
Mark W. Heijenbrok
Eugen B. Hug
Patrick Kalk
Loes M. L. van Kempen-Harteveld
Erik W. Korevaar
Hans Paul van der Laan
Johannes A. Langendijk
Hans J. E. Rozema
Anna L. Petoukhova
Jacobus M. Schippers
Henk Struikmans
John H. Maduro
机构
[1] Radiotherapy Centre West,Department of Radiation Oncology, University Medical Center Groningen
[2] University of Groningen,Department of Radiology
[3] Medical Center Haaglanden,undefined
[4] ProCure Proton Therapy Centers,undefined
[5] Paul Scherrer Institut,undefined
来源
Breast Cancer Research and Treatment | 2014年 / 148卷
关键词
Breath-hold; Breast cancer; IMPT; IMRT; Heart sparing;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose In left-sided breast cancer radiotherapy, tangential intensity modulated radiotherapy combined with breath-hold enables a dose reduction to the heart and left anterior descending (LAD) coronary artery. Aim of this study was to investigate the added value of intensity modulated proton therapy (IMPT) with regard to decreasing the radiation dose to these structures. Methods In this comparative planning study, four treatment plans were generated in 20 patients: an IMPT plan and a tangential IMRT plan, both with breath-hold and free-breathing. At least 97 % of the target volume had to be covered by at least 95 % of the prescribed dose in all cases. Specifically with respect to the heart, the LAD, and the target volumes, we analyzed the maximum doses, the mean doses, and the volumes receiving 5–30 Gy. Results As compared to IMRT, IMPT resulted in significant dose reductions to the heart and LAD-region even without breath-hold. In the majority of the IMPT cases, a reduction to almost zero to the heart and LAD-region was obtained. IMPT treatment plans yielded the lowest dose to the lungs. Conclusions With IMPT the dose to the heart and LAD-region could be significantly decreased compared to tangential IMRT with breath-hold. The clinical relevance should be assessed individually based on the baseline risk of cardiac complications in combination with the dose to organs at risk. However, as IMPT for breast cancer is currently not widely available, IMPT should be reserved for patients remaining at high risk for major coronary events.
引用
收藏
页码:33 / 39
页数:6
相关论文
共 100 条
[1]  
Darby S(2011)Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials Lancet 378 1707-1716
[2]  
McGale P(2005)Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087-2106
[3]  
Clarke M(2009)High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c Radiother Oncol 90 74-79
[4]  
Collins R(2005)Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries Lancet Oncol 6 557-565
[5]  
Darby S(2007)Long-term risk of cardiovascular disease in 10-year survivors of breast cancer J Natl Cancer Inst 99 365-375
[6]  
Kyndi M(2013)Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 987-998
[7]  
Overgaard M(2012)Distribution of coronary artery stenosis after radiation for breast cancer J Clin Oncol 30 380-386
[8]  
Nielsen HM(2008)Cardiac dose from tangential breast cancer radiotherapy in the year 2006 Int J Radiat Oncol Biol Phys 72 501-507
[9]  
Sørensen FB(2011)Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy Radiother Oncol 100 241-246
[10]  
Knudsen H(2013)Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer Am J Clin Oncol 36 24-30